Nanoarchitectured conjugates targeting angiogenesis: investigating heparin-taurocholate acid conjugates (LHT7) as an advanced anti-angiogenic therapy for brain tumor treatment.
- Biomater. Res., Sep 18 2023, 27 (1) 89 | https://doi.org/10.1186/s40824-023-00420-8